Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

Free radicals and antioxidants at a glance using EPR spectroscopy

(2011) Ivan Spasojević   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Immunotherapy for Alzheimer's Disease: Rational Basis in Ongoing Clinical Trials

(2011) Manuel Menendez-Gonzalez et al.   CURRENT PHARMACEUTICAL DESIGN

Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models

(2011) Xiyun Chai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain

(2011) Allal Boutajangout et al.   JOURNAL OF NEUROCHEMISTRY

Prevention of Motor Neuron Degeneration by Novel Iron Chelators in SOD1G93A Transgenic Mice of Amyotrophic Lateral Sclerosis

(2011) Qian Wang et al.   Neurodegenerative Diseases

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

(2010) Douglas B. Kell   ARCHIVES OF TOXICOLOGY

Relevance of the ability of fructose 1,6-bis(phosphate) to sequester ferrous but not ferric ions

(2010) Aleksandar Bajić et al.   CARBOHYDRATE RESEARCH

La citotoxicidad del líquido cefalorraquídeo en la esclerosis lateral amiotrófica

(2010) J. Matías-Guiu et al.   NEUROLOGIA

Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice

(2010) Tohru Hasegawa et al.   PLoS One

Different roles of radical scavengers – ascorbate and urate in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

(2010) Ivan Spasojević et al.   REDOX REPORT

Bioavailability and catalytic properties of copper and iron for Fenton chemistry in human cerebrospinal fluid

(2010) Ivan Spasojević et al.   REDOX REPORT

Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆

(2009) Juan P. Bolaños et al.   ADVANCED DRUG DELIVERY REVIEWS

Frontotemporal Dementia-amyotrophic Lateral Sclerosis Complex is Simulated by Neurodegeneration With Brain Iron Accumulation

(2009) Alexander Frizell Santillo et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

The ALS-Associated Mutation G93A in Human Copper-Zinc Superoxide Dismutase Selectively Destabilizes the Remote Metal Binding Region

(2009) Anna Katrine Museth et al.   BIOCHEMISTRY

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

(2009) Douglas B Kell   BMC Medical Genomics

Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis

(2009) Lana Kupershmidt et al.   FASEB JOURNAL

Neurochemical biomarkers in the differential diagnosis of movement disorders

(2009) Brit Mollenhauer et al.   MOVEMENT DISORDERS

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

(2008) Hayrettin Tumani et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Clinical perspectives of high-resolution mass spectrometry–based proteomics in neuroscience—Exemplified in amyotrophic lateral sclerosis biomarker discovery research

(2008) Titti Ekegren et al.   JOURNAL OF MASS SPECTROMETRY

Increased oxidative stress in patients with amyotrophic lateral sclerosis/Parkinsonism-dementia complex in the Kii peninsula, Japan

(2008) Satoru Morimoto et al.   MOVEMENT DISORDERS

A Golgi fragmentation pathway in neurodegeneration

(2007) Saya Nakagomi et al.   NEUROBIOLOGY OF DISEASE